Institution profile

Vertis Clinic 御成門

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 01C2606035

Location

Prefecture
Tokyo
Address
港区新橋6丁目19番13号 エンスイテ御成門1F

Plan classification

  • Class INot registered
  • Class IIThe medium-risk category under the law.
  • Class IIINot registered

Certified committee for regenerative medicine

  • JSCSF再生医療等委員会

Public score

39.4/ 100

A · Review level
25.0 / 30
B · Technologies
8.0 / 35
C · Coverage
3.6 / 25
D · Class I / II technologies
2.9 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Overall ranking

No. 1218of 1736

Registered technologies
1
Areas covered
1

Technology areas · Rank

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 39.4
Public score →100

Registered technologies (1)

Stem cells (all sources) 1
Registered technologies · Japanese originalTechnology areasPlan classification
動脈硬化関連血管障害リスクの低減を目的とした自己脂肪組織由来幹細胞治療Stem cells (all sources)Adipose-derived stem cellsClass II
Adipose-derived stem cells 1
Registered technologies · Japanese originalTechnology areasPlan classification
動脈硬化関連血管障害リスクの低減を目的とした自己脂肪組織由来幹細胞治療Stem cells (all sources)Adipose-derived stem cellsClass II

Certified committee for regenerative medicine

  • JSCSF再生医療等委員会

Public document number

  • 01C2606035
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
動脈硬化関連血管障害リスクの低減を目的とした自己脂肪組織由来幹細胞治療Class IIJSCSF再生医療等委員会01C2606035

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor